vs
Side-by-side financial comparison of FIRST INTERSTATE BANCSYSTEM INC (FIBK) and Bio-Techne (TECH). Click either name above to swap in a different company.
FIRST INTERSTATE BANCSYSTEM INC is the larger business by last-quarter revenue ($313.0M vs $295.9M, roughly 1.1× Bio-Techne). FIRST INTERSTATE BANCSYSTEM INC runs the higher net margin — 34.8% vs 12.8%, a 21.9% gap on every dollar of revenue. On growth, FIRST INTERSTATE BANCSYSTEM INC posted the faster year-over-year revenue change (19.8% vs -6.4%). Over the past eight quarters, FIRST INTERSTATE BANCSYSTEM INC's revenue compounded faster (13.7% CAGR vs 4.2%).
First Interstate BancSystem, Inc. is a financial holding company headquartered in Billings, Montana. It is the parent company of First Interstate Bank, a community bank with locations throughout 14 states within the Western and Midwestern United States. It is the largest bank based in Montana, as measured by total assets.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FIBK vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $313.0M | $295.9M |
| Net Profit | $108.8M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 44.5% | 18.4% |
| Net Margin | 34.8% | 12.8% |
| Revenue YoY | 19.8% | -6.4% |
| Net Profit YoY | 108.8% | 68.3% |
| EPS (diluted) | $1.07 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $313.0M | $295.9M | ||
| Q3 25 | $250.5M | — | ||
| Q2 25 | $248.3M | $317.0M | ||
| Q1 25 | $247.0M | $316.2M | ||
| Q4 24 | $261.3M | $297.0M | ||
| Q3 24 | $251.9M | $289.5M | ||
| Q2 24 | $244.3M | $306.1M | ||
| Q1 24 | $242.2M | $303.4M |
| Q4 25 | $108.8M | $38.0M | ||
| Q3 25 | $71.4M | — | ||
| Q2 25 | $71.7M | $-17.7M | ||
| Q1 25 | $50.2M | $22.6M | ||
| Q4 24 | $52.1M | $34.9M | ||
| Q3 24 | $55.5M | $33.6M | ||
| Q2 24 | $60.0M | $40.6M | ||
| Q1 24 | $58.4M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 44.5% | 18.4% | ||
| Q3 25 | 37.0% | — | ||
| Q2 25 | 37.7% | -7.5% | ||
| Q1 25 | 26.9% | 12.2% | ||
| Q4 24 | 25.5% | 16.0% | ||
| Q3 24 | 28.9% | 13.8% | ||
| Q2 24 | 32.1% | 15.0% | ||
| Q1 24 | 31.7% | 22.1% |
| Q4 25 | 34.8% | 12.8% | ||
| Q3 25 | 28.5% | — | ||
| Q2 25 | 28.9% | -5.6% | ||
| Q1 25 | 20.3% | 7.1% | ||
| Q4 24 | 19.9% | 11.7% | ||
| Q3 24 | 22.0% | 11.6% | ||
| Q2 24 | 24.6% | 13.3% | ||
| Q1 24 | 24.1% | 16.2% |
| Q4 25 | $1.07 | $0.24 | ||
| Q3 25 | $0.69 | — | ||
| Q2 25 | $0.69 | $-0.11 | ||
| Q1 25 | $0.49 | $0.14 | ||
| Q4 24 | $0.50 | $0.22 | ||
| Q3 24 | $0.54 | $0.21 | ||
| Q2 24 | $0.58 | $0.26 | ||
| Q1 24 | $0.57 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $172.9M |
| Total DebtLower is stronger | $146.3M | $260.0M |
| Stockholders' EquityBook value | $3.4B | $2.0B |
| Total Assets | $26.6B | $2.5B |
| Debt / EquityLower = less leverage | 0.04× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | — | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | $146.3M | $260.0M | ||
| Q3 25 | $146.2M | — | ||
| Q2 25 | $252.0M | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $132.2M | $300.0M | ||
| Q3 24 | $137.3M | $300.0M | ||
| Q2 24 | $383.4M | $319.0M | ||
| Q1 24 | $370.8M | $389.0M |
| Q4 25 | $3.4B | $2.0B | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | $1.9B | ||
| Q1 25 | $3.4B | $2.0B | ||
| Q4 24 | $3.3B | $2.1B | ||
| Q3 24 | $3.4B | $2.1B | ||
| Q2 24 | $3.2B | $2.1B | ||
| Q1 24 | $3.2B | $2.0B |
| Q4 25 | $26.6B | $2.5B | ||
| Q3 25 | $27.3B | — | ||
| Q2 25 | $27.6B | $2.6B | ||
| Q1 25 | $28.3B | $2.6B | ||
| Q4 24 | $29.1B | $2.7B | ||
| Q3 24 | $29.6B | $2.7B | ||
| Q2 24 | $30.3B | $2.7B | ||
| Q1 24 | $30.1B | $2.7B |
| Q4 25 | 0.04× | 0.13× | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.04× | 0.14× | ||
| Q3 24 | 0.04× | 0.14× | ||
| Q2 24 | 0.12× | 0.15× | ||
| Q1 24 | 0.12× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $305.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 2.81× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $305.6M | — | ||
| Q3 25 | $91.7M | — | ||
| Q2 25 | $68.1M | $98.2M | ||
| Q1 25 | $78.5M | $41.1M | ||
| Q4 24 | $355.0M | $84.3M | ||
| Q3 24 | $89.9M | $63.9M | ||
| Q2 24 | $82.3M | $75.5M | ||
| Q1 24 | $87.6M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $57.5M | ||
| Q1 24 | — | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.28× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 1.56× | 1.82× | ||
| Q4 24 | 6.81× | 2.42× | ||
| Q3 24 | 1.62× | 1.90× | ||
| Q2 24 | 1.37× | 1.86× | ||
| Q1 24 | 1.50× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIBK
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
